Alfian Sofa D, Khoiry Qisty A, Griselda Meliana, Pradipta Ivan S, Nursiswati Nursiswati, Abdulah Rizky
Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jl. Raya Jatinangor, KM 21, Jatinangor, Sumedang, Indonesia.
Drug Utilization and Pharmacoepidemiology Research Group, Center of Excellence for Pharmaceutical Care Innovation, Universitas Padjadjaran, Jatinangor, Indonesia.
Sci Rep. 2025 Jul 11;15(1):25078. doi: 10.1038/s41598-025-09688-3.
The COVID-19 is known to be a severe pandemic that has accelerated the adoption of telepharmacy services. However, little is known about the current practices and willingness of patients with chronic diseases in the new-norm, specifically in a setting where such services are not properly established before the pandemic. The main objective of this study was to assess the current practices and willingness to use telepharmacy services as well as to identify factors associated with low willingness among patients with chronic diseases in Bandung City in Indonesia. A multisite cross-sectional survey was conducted in seven community health centers (CHCs) and one hospital in Bandung City, in Indonesia, which were selected based on the highest number of patients with chronic diseases. The survey utilized a purposive sampling method among patients with hypertension, dyslipidemia, diabetes, chronic obstructive pulmonary diseases (COPD), and/or chronic kidney diseases. Current practices and willingness to use telepharmacy services were evaluated through a paper-based questionnaire. Binary logistic regression analyses were performed to determine factors associated with low willingness to use telepharmacy services. Odds ratios (ORs) with 95% confidence intervals (CIs) were reported. A total of 443 patients with chronic diseases were participated, with most having hypertension. Overall, both current practices and willingness to use telepharmacy services were low. Factors associated with low willingness included being 50 years or older (OR = 3.41; 95%CI = 1.46-7.97), inability to use the internet (OR = 3.92; 95% CI = 1.12-13.76), using smartphones independently (OR = 3.64; 95% CI = 1.13-11.72) or with assistance (OR = 6.75; 95% CI = 1.47-31.07), and daily phone usage of less than an hour (OR = 5.50; 95% CI = 1.08-27.89). The study indicated low practices and willingness to use telepharmcy services among patients with chronic diseases. As a result, patients-specific factors such as older age, inability to use the internet, as well as low daily use of smartphones that associated with the low willingness to use telepharmacy services should be considered in order to facilitate telepharmacy implementation in Indonesia.
众所周知，新冠疫情是一场严重的大流行病，加速了远程药学服务的采用。然而，对于慢性病患者在新常态下的当前做法和意愿，尤其是在疫情前此类服务尚未妥善建立的环境中，人们了解甚少。本研究的主要目的是评估印度尼西亚万隆市慢性病患者使用远程药学服务的当前做法和意愿，并确定与低意愿相关的因素。在印度尼西亚万隆市的七个社区卫生中心（CHC）和一家医院进行了多地点横断面调查，这些机构是根据慢性病患者数量最多来选择的。该调查在高血压、血脂异常、糖尿病、慢性阻塞性肺疾病（COPD）和/或慢性肾脏病患者中采用了目的抽样方法。通过纸质问卷评估使用远程药学服务的当前做法和意愿。进行二元逻辑回归分析以确定与使用远程药学服务的低意愿相关的因素。报告了具有95%置信区间（CI）的比值比（OR）。共有443名慢性病患者参与，其中大多数患有高血压。总体而言，使用远程药学服务的当前做法和意愿都很低。与低意愿相关的因素包括年龄在50岁及以上（OR = 3.41；95%CI = 1.46 - 7.97）、无法使用互联网（OR = 3.92；95%CI = 1.12 - 13.76）、独立使用智能手机（OR = 3.64；95%CI = 1.13 - 11.72）或在协助下使用智能手机（OR = 6.75；95%CI = 1.47 - 31.07），以及每日电话使用时间少于一小时（OR = 5.50；95%CI = 1.08 - 27.89）。该研究表明慢性病患者使用远程药学服务的做法和意愿较低。因此，为了促进印度尼西亚远程药学的实施，应考虑年龄较大、无法使用互联网以及智能手机日常使用较少等与使用远程药学服务的低意愿相关的患者特定因素。
